A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
for Advanced Solid Tumors Cancer
Sites in Providence +9 more locations
Sponsor: Nimbus Wadjet, Inc.
Sex: All·Age: 18 - 99
Code: NCT06898450·Phase 1, Phase 2·Recruiting·Listed Mar 2025